Abstract
Type 2 diabetes results from impaired action and secretion of insulin. It is not known whether the two defects share a common pathogenesis. We show that haploinsufficiency of the Foxo1 gene, encoding a forkhead transcription factor (forkhead box transcription factor O1), restores insulin sensitivity and rescues the diabetic phenotype in insulin-resistant mice by reducing hepatic expression of glucogenetic genes and increasing adipocyte expression of insulin-sensitizing genes. Conversely, a gain-of-function Foxo1 mutation targeted to liver and pancreatic β-cells results in diabetes arising from a combination of increased hepatic glucose production and impaired β-cell compensation due to decreased Pdx1 expression. These data indicate that Foxo1 is a negative regulator of insulin sensitivity in liver, adipocytes and pancreatic β-cells. Impaired insulin signaling to Foxo1 provides a unifying mechanism for the common metabolic abnormalities of type 2 diabetes.
NOTE: In the AOP version of this article, the name of the fourth author was misspelled as W K Cavanee rather than the correct spelling: W K Cavenee. This has been corrected in the full-text online version of the article. The name will appear correctly in the print version.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
£139.00 per year
only £11.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
09 September 2002
This was incorrect in AOP version but corrected in print. Changed the spelling of fourth author's last name from incorrect Cavanee to correct Cavenee
References
National Diabetes Data Group. Diabetes in America (National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, 1995).
Saltiel, A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104, 517–529 (2001).
Taylor, S.I., Accili, D. & Imai, Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 43, 735–740 (1994).
Bergman, R.N. & Ader, M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab. 11, 351–356 (2000).
Hotamisligil, G.S. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int. J. Obes. Relat. Metab. Disord. 24 (Suppl. 4), S23–S27 (2000).
Michael, M.D. et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6, 87–97 (2000).
Rother, K.I. et al. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J. Biol. Chem. 273, 17491–17497 (1998).
Withers, D.J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900–904 (1998).
Kulkarni, R.N. et al. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96, 329–339 (1999).
Kulkarni, R.N. et al. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines. J. Clin. Invest. 104, R69–75 (1999).
Kubota, N. et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes 49, 1880–1889 (2000).
Nakae, J., Kido, Y. & Accili, D. Tissue-specific insulin resistance in type 2 diabetes: lessons from gene-targeted mice. Ann. Med. 33, 22–27 (2001).
Kaestner, K.H., Knochel, W. & Martinez, D.E. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14, 142–146 (2000).
Lin, K., Dorman, J.B., Rodan, A. & Kenyon, C. Daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278, 1319–1322 (1997).
Ogg, S. et al. The Forkhead transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994–999 (1997).
Apfeld, J. & Kenyon, C. Cell nonautonomy of C. elegans daf-2 function in the regulation of diapause and life span. Cell 95, 199–210 (1998).
Lin, K., Hsin, H., Libina, N. & Kenyon, C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nature Genet. 28, 139–145 (2001).
Accili, D. et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nature Genet. 12, 106–109 (1996).
Nakae, J., Park, B.-C. & Accili, D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a wortmannin-sensitive pathway. J. Biol. Chem. 274, 15982–15985 (1999).
Anderson, M.J., Viars, C.S., Czekay, S., Cavenee, W.K. & Arden, K.C. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47, 187–199 (1998).
Nasrin, N. et al. DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells. Proc. Natl Acad. Sci. USA 97, 10412–10417 (2000).
Bruning, J.C. et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561–572 (1997).
Kido, Y., Philippe, N., Schaeffer, A.A. & Accili, D. Genetic modifiers of the insulin resistance phenotype. Diabetes 49, 589–596 (2000).
Kido, Y. et al. Tissue-specific insulin resistance in mice with combined mutations of Insulin Receptor, IRS-1 and IRS-2. J. Clin. Invest. 105, 199–205 (2000).
Shen, W., Scearce, L.M., Brestelli, J.E., Sund, N.J. & Kaestner, K.H. Foxa3 (Hepatocyte Nuclear Factor 3γ) is required for the regulation of hepatic glut2 expression and the maintenance of glucose homeostasis during a prolonged fast. J. Biol. Chem. 276, 42812–42817 (2001).
Nakae, J., Kitamura, T., Biggs, W., Arden, K. & Accili, D. The forkhead transcription factor FKHR inhibits adipocyte differentiation. Diabetes 50 (Suppl. 2), A22 (2001).
Datta, S.R., Brunet, A. & Greenberg, M.E. Cellular survival: a play in three Akts. Genes Dev. 13, 2905–2927 (1999).
Nakae, J., Barr, V. & Accili, D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. EMBO J. 19, 989–996 (2000).
Yan, C., Costa, R.H., Darnell, J.E., Jr., Chen, J.D. & Van Dyke, T.A. Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J. 9, 869–878 (1990).
Allen-Jennings, A.E., Hartman, M.G., Kociba, G.J. & Hai, T. The roles of atf3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas. J. Biol. Chem. 276, 29507–29514 (2001).
Jacobsson, B. et al. Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets. J. Histochem. Cytochem. 37, 31–37 (1989).
Cherrington, A.D. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48, 1198–1214 (1999).
Bonner-Weir, S. et al. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl Acad. Sci. USA 97, 7999–8004 (2000).
Bouwens, L. & Pipeleers, D.G. Extra-insular β cells associated with ductules are frequent in adult human pancreas. Diabetologia 41, 629–633 (1998).
Sharma, A. et al. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48, 507–513 (1999).
Nakae, J., Kitamura, T., Silver, D.L. & Accili, D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J. Clin. Invest. 108, 1359–1367 (2001).
Kitamura, T. et al. The transcription factor FKHR regulates pancreatic β cell survival. Diabetes 50 (Suppl. 2), A345 (2001).
Kadowaki, T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J. Clin. Invest. 106, 459–465 (2000).
Bonner-Weir, S. Life and death of the pancreatic β cells. Trends Endocrinol. Metab. 11, 375–378 (2000).
Kitamura, T. et al. Preserved pancreatic β-cell development and function in mice lacking the insulin receptor-related receptor. Mol. Cell. Biol. 21, 5624–5630 (2001).
Acknowledgements
This work was supported by grants from the US National Institutes of Health and the Juvenile Diabetes Research Foundation. We thank B. Thorens (Univ. of Lausanne) for the mouse Slc2a2 cDNA and Y. Liu for help with immunohistochemistry.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Nakae, J., Biggs, W., Kitamura, T. et al. Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32, 245–253 (2002). https://doi.org/10.1038/ng890
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng890
This article is cited by
-
Transcription factor FoxO1 regulates myoepithelial cell diversity and growth
Scientific Reports (2024)
-
O-GlcNAcylation mediates H2O2-induced apoptosis through regulation of STAT3 and FOXO1
Acta Pharmacologica Sinica (2024)
-
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure
Nature Communications (2023)
-
Targeting pancreatic β cells for diabetes treatment
Nature Metabolism (2022)
-
The transcriptional corepressor CtBP2 serves as a metabolite sensor orchestrating hepatic glucose and lipid homeostasis
Nature Communications (2021)